Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced its financial results for the second quarter of fiscal year 2025.

In less than a month, Washington Square (and Holland) will have a new go-to spot for all things books and records.

If U.S. District Judge K. Michael Moore in Miami denies dismissal under Federal Rules of Civil Procedure 12(b)(6) or to ...

Venus Williams’ recent singles win at the D.C. Open showcased her longevity and brought attention to health coverage for ...

Large Deal Wins at $3.8 Billion with 55% Net New; Demonstrating Deep Competitive Advantage in Consolidation Play - FY26 Revenue ...

Hexaware Technologies (NSE: HEXT), a leading global provider of IT solutions and services, today announced financial results for the second quarter of calendar year 2025 ended June 30, 2025. Financial ...

Q2 2025 Earnings Call Transcript July 24, 2025 TransUnion beats earnings expectations. Reported EPS is $1.08, expectations ...

Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems ...

In the rolling hills of Blair County sits a bargain hunter’s paradise that defies the digital age – Leighty’s Outdoor Flea Market in Newry, Pennsylvania, where treasure hunting isn’t just a hobby, ...

Consolidated Edison Inc. closed 11.00% below its 52-week high of $114.87, which the company reached on April 4th.

Italian hearing aid company Amplifon's second-quarter core profit dropped 8.7% to 147.3 million euros ($169.84 million) on ...